Ultratech Cement Ltd.
NSE: ULTRACEMCO
Basic Materials · Building Materials
Research updated
NSE: AARTIINDBasic MaterialsSpecialty Chemicals
Create an account, then follow this company for weekday briefs. You will return to Aarti Industries after signing in.
Aarti Industries Ltd. is a leading Indian chemical manufacturer specializing in the production of specialty chemicals and pharmaceuticals. The company's primary focus lies in creating a diverse portfolio of high-performance chemicals that serve various industries including agrochemicals, polymers, pigments, and pharmaceuticals. Notable for its robust capabilities in chemistry, Aarti Industries Ltd. provides crucial intermediates that support global industrial applications ranging from manufacture of dyes and pigments, additives, to those required in healthcare and agrichemicals. The company is strategically significant in the chemical supply chain, enabling sectors to enhance product performance and efficiency. Headquartered in Mumbai, India, Aarti Industries Ltd. leverages cutting-edge technology and infrastructure, ensuring compliance with rigorous safety and environmental standards. Its expansive production and R&D facilities allow for continuous innovation and adaptability, reinforcing its market position both domestically and internationally. As such, Aarti Industries Ltd. plays a pivotal role in bridging raw chemical production and end-user product transformations across multiple industry sectors.
Public research · Report of
Aarti Industries (NSE: AARTIIND), Speciality chemicals and aromatic intermediates: revenue of ₹8,286 crore in FY26 (+14.0% on FY25), an EBITDA margin of 14.1%, net profit of ₹419.1 crore and net debt of ₹4,310 crore.
Indian integrated manufacturer of speciality chemicals and intermediates across benzene, toluene and sulphuric-acid value chains, serving agrochemicals, polymers, pigments, pharmaceuticals and other industrial applications. Process expertise includes chlorination, nitration, hydrogenation and advanced custom synthesis. Overseas trading subsidiaries and chemical/circularity JVs complement Indian manufacturing. The pharmaceutical undertaking was demerged and is not consolidated as Aarti Pharmalabs.
| Item | Value |
|---|---|
| Legal name | Aarti Industries Limited (formerly Aarti Organic Private Limited) |
| Exchange and ticker | NSE: AARTIIND; BSE: 524208 |
| ISIN | INE769A01020 |
| CIN | L24110GJ1984PLC007301 |
| Sector | Materials |
| Industry | Speciality chemicals and aromatic intermediates |
| Headquarters | Mumbai, India |
| Fiscal year end | March |
| Reporting basis and unit | consolidated, in ₹ crore |
| Auditor | Gokhale & Sathe |
| Market capitalisation | ₹17,815 crore (16 Oct 2026) |
| Shares outstanding | 36.26 crore shares (FY26) |
| Price | ₹505.0 (close, 16 Oct 2026) |
| 52-week range | ₹338.0 - ₹551.8 (to 16 Oct 2026) |
| Website | https://www.aarti-industries.com |
| Entity | Holding | Business |
|---|---|---|
| Aarti Corporate Services Limited | 100% | Corporate services/investment holding; holds indirect subsidiary interests. |
| Innovative Envirocare Jhagadia Limited | 100% | Environmental services; no FY26 turnover reported. |
| Aarti Polychem Private Limited | 100% | Chemical subsidiary; no FY26 turnover reported. |
| Aarti Bharuch Limited | 100% | Chemical/project subsidiary. |
| Aarti Circularity Limited | 100% | Former Aarti Spechem; circularity ventures including 49% Re-Aarti JV. |
| Alchemie (Europe) Limited | 88.89% | European chemical trading subsidiary. |
| Aarti Chemical Trading - FZCO | 100% | UAE chemical trading; designated material subsidiary from 1 April 2026. |
| Aarti Chem Trading USA Inc. | 100% | US chemical trading; indirect through FZCO, incorporated 1 July 2024. |
As of cutoff excludes Shanti Intermediates: subsidiary at FY26 year end, ceased 23 June 2026. JVs (not subsidiaries): Augene 50%, Re-Aarti 49% through Circularity; equity method. No associates. Nascent ceased before FY26; disposal detail not retrieved.
| Shareholding (% of shares) | Q3FY26 | Q4FY26 | Q1FY27 | Q2FY27 |
|---|---|---|---|---|
| Promoter | 42.14% | 42.09% | 41.82% | |
| Foreign institutions | 6.70% | 7.38% | 7.00% | |
| Domestic institutions | 18.22% | 20.12% | 21.11% | |
| of which mutual funds | 10.20% | 11.51% | 12.12% |
The promoter holding pledged is a share of the promoter's own holding.
Aarti Industries is an integrated aromatic and sulphur-chain intermediates manufacturer. End uses are energy/fuel additives, agrochemicals, pharmaceuticals, dyes and polymers. MMA means monomethyl aniline, not methyl methacrylate. Product tonnes overlap through captive downstream conversion and cannot be added as external sales. One statutory segment, Specialty Chemicals; end-use revenue shares are not profit segments. Subsidiaries are consolidated; Augene and ReAarti are joint ventures accounted through share of PAT, not consolidated EBITDA.
| Peer | Why the dossier compares them |
|---|---|
| Atul Limited (ATUL) | Integrated aromatic intermediates, dyes and crop-protection chemistry; similar multi-end-use chemical manufacturing, though more diversified. |
| Deepak Nitrite Limited (DEEPAKNTR) | Nitro-toluidines, xylidines and cumidines; aromatic intermediates comparator. Phenolics mix limits margins; specific reaction overlap not confirmed in retrieved passage. |
| Anupam Rasayan India Limited (ANURAS) | Specialty intermediates for crop protection, pharma and performance materials; end-use/process-scale-up comparator. Specific reactions/CDMO not established in retrieved passage. |
| Navin Fluorine International Limited (NAVINFLUOR) | Complex multistep fluorinated/nonfluorinated CDMO and specialty intermediates; scale-up/custom synthesis comparator. Refrigerant/fluorine feedstock mix differs. |
| SRF Limited (SRF) | Industrial and specialty intermediates: chemicals-division comparator. Films/foil and textiles distort group margins; specific reaction overlap not confirmed. |
| Vinati Organics Limited (VINATIORGA) | Integrated aromatic derivatives and niche organic intermediates; comparable chemistry-led scale-up, but concentrated portfolio differs. |
| Profit and loss (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Net revenue from operations excluding GST | 5,191 | 6,492 | 6,372 | 7,269 | 8,286 |
| Cost of revenue (vendor classification) * | 3,602 | 4,695 | 4,655 | 4,655 | 6,128 |
| Other operating costs (vendor classification) * | 2,327 | 1,734 | 1,421 | 1,602 | 1,915 |
| EBITDA (vendor classification) * | 1,687 | 1,028 | 962.4 | 1,014 | 1,141 |
| Operating EBIT excluding other income | 1,441 | 717.4 | 598.5 | 562.8 | 693.4 |
| Finance costs including borrowing forex | 68.6 | 106.3 | 211.5 | 275.4 | 339.9 |
| Profit before tax after exceptional items | 1,372 | 611.1 | 395.4 | 307.3 | 364.8 |
| Total tax expense negative for credit | 186.3 | 65.9 | -21.1 | -23.6 | -54.3 |
| PAT before NCI and equity-accounted share | 1,186 | 545.2 | 416.5 | 330.9 | 419.2 |
| Diluted EPS (₹) | 32.71 | 15.04 | 11.49 | 9.12 | 11.55 |
| Materials, purchases and inventory change | 3,880 | 4,655 | 5,349 | ||
| Employee benefits expense | 403.7 | 447.1 | 422.1 | ||
| Other expenses including operating forex | 1,112 | 1,170 | 1,347 | ||
| Operating EBITDA excluding other income | 976.6 | 997.1 | 1,168 | ||
| Other income excluding exceptional income | 8.41 | 17.5 | 4.87 | ||
| Depreciation and amortisation expensed | 378.1 | 434.3 | 474.1 | ||
| Exceptional net gain positive | 0.00 | 2.37 | 6.47 | ||
| PAT attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | ||
| Share of associate/JV profit or loss | 0.00 | -0.06 | -0.12 | ||
| PAT attributable to owners | 416.5 | 330.9 | 419.1 |
| Balance sheet (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Total equity including NCI | 4,517 | 4,921 | 5,290 | 5,605 | 5,955 |
| Gross loans and borrowings excluding leases | 2,587 | 2,907 | 3,184 | 3,790 | 4,921 |
| Cash and cash equivalents | 93.6 | 167.5 | 41.8 | 199.4 | 582.7 |
| Trade receivables | 1,092 | 940.5 | 826.4 | 786.1 | 1,403 |
| Inventories | 934.1 | 1,031 | 1,160 | 1,454 | 1,732 |
| Trade payables | 344.9 | 215.6 | 521.3 | 1,237 | 1,841 |
| Net tangible PPE | 147.4 | 159.4 | 5,588 | 6,277 | 6,265 |
| Capital work in progress | 1,409 | 1,041 | 1,052 | 1,274 | 2,030 |
| Total assets | 7,851 | 8,581 | 9,616 | 11,114 | 13,300 |
| Other bank balances including earmarked balances | 88.0 | 95.6 | 25.7 | ||
| Noncurrent investments not all liquid | 22.9 | 47.6 | 132.3 | ||
| Company net debt less cash and marketable securities | 3,050 | 3,492 | 4,310 | ||
| Cash and marketable securities net debt deduction | 133.5 | 297.6 | 610.6 | ||
| Current and noncurrent lease liabilities | 58.4 | 58.2 | 45.3 | ||
| Paid up equity share capital | 181.3 | 181.3 | 181.3 |
| Cash flow (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 531.0 | 1,050 | 1,204 | 1,238 | 780.8 |
| Free cash flow (vendor definition) * | -646.8 | -7.56 | -124.2 | 1,242 | -343.5 |
| Dividends paid (the provider's sign: an outflow is negative) | -126.9 | -90.6 | -54.4 | -36.3 | -36.3 |
| Gross cash additions to PPE and capital WIP outflow | -1,165 | -1,326 | -1,328 | -1,382 | -1,124 |
| CFO less gross cash capex | -124.2 | -144.3 | -343.5 |
| Other reported lines (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Actual year end shares crore | 36.25 | 36.25 | 36.25 | 36.25 | 36.26 |
| Weighted average diluted shares crore | 36.25 | 36.28 | 36.27 | ||
| Company gross revenue including GST | 7,012 | 8,044 | 9,018 |
| Quarterly profit and loss (₹ crore) | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations (net of GST) | 1,628 | 1,843 | 1,949 | 1,676 | 2,100 | 2,319 | 2,206 | 2,387 |
| Cost of revenue (vendor classification) * | 1,017 | 1,229 | 1,251 | 1,122 | 1,531 | 1,321 | 1,532 | |
| Other operating costs (vendor classification) * | 310.0 | 273.0 | 324.0 | 249.0 | 355.0 | 446.0 | 399.0 | |
| EBITDA (vendor classification) * | 202.0 | 236.0 | 265.0 | 216.0 | 323.0 | 342.0 | 385.0 | |
| EBIT excluding other income | 89.0 | 120.0 | 150.0 | 98.0 | 171.0 | 200.0 | 224.0 | 258.0 |
| Finance costs including loan FX revaluation | 62.0 | 85.0 | 64.0 | 60.0 | 100.0 | 69.0 | 112.0 | 83.0 |
| Profit before tax | 34.0 | 40.0 | 88.0 | 42.0 | 93.0 | 118.0 | 111.0 | 180.0 |
| Total tax expense (credit negative) | -18.0 | -6.00 | -7.00 | -1.00 | -12.0 | -14.0 | -26.0 | 25.0 |
| Consolidated profit before NCI attribution | 52.0 | 46.0 | 96.0 | 43.0 | 106.0 | 133.0 | 137.0 | 155.0 |
| Diluted EPS (₹) | 1.44 | 1.27 | 2.64 | 1.19 | 2.91 | 3.66 | 3.78 | 4.26 |
| Materials + trade purchases + inventory change | 1,017 | 1,229 | 1,251 | 1,122 | 1,375 | 1,531 | 1,321 | 1,532 |
| Employee benefits expense | 105.0 | 105.0 | 105.0 | 109.0 | 105.0 | 106.0 | 103.0 | 120.0 |
| Other expenses (reported; separate trade FX excluded) | 310.0 | 273.0 | 324.0 | 249.0 | 314.0 | 355.0 | 446.0 | 399.0 |
| EBITDA excl. other income (operating, same basis as annual) | 197.0 | 231.0 | 262.0 | 212.0 | 291.0 | 321.0 | 343.0 | 382.0 |
| Other income | 5.00 | 5.00 | 3.00 | 4.00 | 0.00 | 2.00 | -1.00 | 3.00 |
| Depreciation and amortisation | 108.0 | 111.0 | 113.0 | 114.0 | 120.0 | 121.0 | 119.0 | 124.0 |
| Exceptional gain positive; expense negative | 2.00 | 0.00 | 0.00 | 0.00 | 22.0 | -15.0 | 0.00 | 2.00 |
| Profit attributable to non-controlling interests | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Share of associates and joint ventures profit/loss | n.d. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit attributable to owners | 52.0 | 46.0 | 96.0 | 43.0 | 106.0 | 133.0 | 137.0 | 155.0 |
| Gross revenue from operations including GST | 1,786 | 2,038 | 2,214 | 1,867 | 2,250 | 2,492 | 2,422 | 2,627 |
| GST collected (deducted from gross revenue) | 158.0 | 195.0 | 265.0 | 192.0 | 150.0 | 174.0 | 217.0 | 240.0 |
| Cost of materials consumed | 1,059 | 1,159 | 1,104 | 1,060 | 1,317 | 1,385 | 1,495 | 1,647 |
| Purchases of stock in trade | 39.0 | 34.0 | 72.0 | 73.0 | 77.0 | 215.0 | 235.0 | 190.0 |
| Changes in FG, WIP and stock-in-trade inventories | -81.0 | 36.0 | 75.0 | -11.0 | -19.0 | -69.0 | -409.0 | -305.0 |
| Trade FX loss (gain negative), operating | 0.00 | 3.00 | 6.00 | -16.0 | 15.0 | 5.00 | -6.00 | -46.0 |
| Profit before exceptional items and tax | 32.0 | 40.0 | 88.0 | 42.0 | 72.0 | 134.0 | 111.0 | 178.0 |
| Total income, as reported | 1,632 | 1,847 | 1,952 | 1,679 | 2,100 | 2,321 | 2,205 | 2,390 |
| Total expenses, as reported | 1,601 | 1,807 | 1,863 | 1,637 | 2,028 | 2,187 | 2,094 | 2,211 |
| Current year tax | 8.00 | 7.00 | 15.0 | 8.00 | 15.0 | 20.0 | 22.0 | 24.0 |
| Earlier year tax (dash or rounded0 normalised zero) | -1.00 | 0.00 | -3.00 | 0.00 | -3.00 | 0.00 | 0.00 | 0.00 |
| MAT credit utilised/(entitlement); entitlement negative | -18.0 | -7.00 | -15.0 | -8.00 | -15.0 | -20.0 | -21.0 | 0.00 |
| Deferred tax (credit negative) | -7.00 | -6.00 | -4.00 | -2.00 | -10.0 | -15.0 | -27.0 | 1.00 |
Consolidated, as reported. Lines marked * are the market-data provider's figures; the rest are extracted from the company's filings or derived from them. n.d. not disclosed, n.r. not retrieved, n.a. not applicable.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue growth | 20.6% | 25.1% | -1.8% | 14.1% | 14.0% |
| EBITDA margin | 15.3% | 13.7% | 14.1% | ||
| Net margin | 6.5% | 4.6% | 5.1% | ||
| Return on equity | 8.2% | 6.1% | 7.2% | ||
| Return on capital employed | 21.4% | 9.6% | 7.3% | 6.3% | 6.8% |
| Return on assets | 4.6% | 3.2% | 3.4% | ||
| Net debt (₹ crore) | 3,050 | 3,492 | 4,310 | ||
| Net debt / EBITDA | 3.12x | 3.50x | 3.69x | ||
| Interest cover | 21.0x | 6.75x | 2.83x | 2.04x | 2.04x |
| Asset turnover | 0.67x | 0.79x | 0.70x | 0.70x | 0.68x |
| Receivable days | 77 | 53 | 47 | 39 | 62 |
| Inventory days (on revenue) | 66 | 58 | 66 | 73 | 76 |
| Payable days (on revenue) | 24 | 12 | 30 | 62 | 81 |
| Cash conversion | 2.89x | 3.74x | 1.86x | ||
| Capex intensity | 22.4% | 20.4% | 20.8% | 19.0% | 13.6% |
| Free cash flow (₹ crore) | -634.0 | -276.7 | -124.2 | -144.3 | -343.5 |
| Dividend payout | 13.1% | 11.0% | 8.7% | ||
| EPS, diluted (₹) | 32.71 | 15.04 | 11.49 | 9.12 | 11.55 |
| Book value per share (₹) | 124.6 | 135.7 | 145.9 | 154.6 | 164.2 |
Computed from the statements above:
Source: the company's filings and disclosures as extracted into Mool's company dossier (version 1, information to 16 Oct 2026); market data at the close of 16 Oct 2026. Every figure is read from the dossier's files or computed from them; the account of the business model is the analyst's, from the dossier's workings.
With Individual or above
Every piece of Mool’s research is built the same way: a researched evidence base, analyses that build on each other, a research model and a report with the call. This page shows the first analysis.
The model behind the report: the company’s history, the drivers that move it, its forecasts by scenario and the valuation the 12-month target comes from.
Individual or above opens every piece of research Mool has published. A new account can start with 10 days of Pro, or of Firm on a work email address. No card needed.
Report history
Same sector
NSE: ULTRACEMCO
Basic Materials · Building Materials
Research updated
NSE: JSWSTEEL
Basic Materials · Steel
Research updated
NSE: ASIANPAINT
Basic Materials · Specialty Chemicals
Research updated
NSE: HINDZINC
Basic Materials · Other Industrial Metals & Mining
Research updated
NSE: TATASTEEL
Basic Materials · Steel
Research updated
NSE: HINDALCO
Basic Materials · Aluminum
Research updated
Prices are the last close on the NSE, 23 Oct 2026. Research from Mool’s report of 16 Oct 2026; page updated 25 Oct 2026.
Mool’s research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, registration INH000012449, which is responsible for it. This page shows factual company information and an excerpt of that research; it carries no rating and is not investment advice for any individual. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Read the disclosures.